- Optegra’s European ophthalmology platform operates in Poland, the Czech Republic, Slovakia and the UK
- The company operates 29 facilities and performs over 100k surgical procedures per year
- Optegra operates seven dedicated eye hospitals in the UK, in Birmingham, Hampshire, Manchester, London, Surrey and Yorkshire
MidEuropa announced that it has entered into a definitive agreement to acquire a majority stake in Optegra Eye Health Care. The company’s management team are reinvesting alongside MidEuropa and the current sponsor, H2 Equity Partners.
Optegra is a European ophthalmology platform operating in Poland, Czech Republic, Slovakia and the UK. The London-based company offers a range of procedures including cataract, AMD, and vision correction for both public and private patients. Optegra operates 29 and performs over 100k surgical procedures per year.
“Optegra is a fast-growing European healthcare player ideally positioned to deliver organic growth within its current footprint and expand into new geographies,” said Pawel Malicki, principal at MidEuropa. “We have closely followed Optegra’s development over the past few years and are impressed with its progress and excited to work with the management and H2 Equity Partners in building a pan-European ophthalmology champion.”
MidEuropa is a buyout investor, focused on the growth markets of Central and Eastern Europe with approximately €6 billion of funds raised. The firm has offices in Warsaw, London, Bucharest, Luxembourg and Guernsey.
H2 Equity Partners, headquartered in London, is an investment firm focusing on the United Kingdom, Ireland and the Benelux.